Viewing StudyNCT00040105



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00040105
Status: COMPLETED
Last Update Posted: 2012-08-01
First Post: 2002-06-19

Brief Title: Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous Leukemia
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: ID02-169
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Johnson Johnson Pharmaceutical Research Development LLC INDUSTRY